Matching-adjusted indirect comparisons of efficacy of BAY 81-8973 vs two recombinant factor VIII for the prophylactic treatment of severe hemophilia A

BACKGROUND: No head-to-head trials comparing recombinant factor VIII (rFVIII) products currently exist. This was a matching-adjusted indirect comparison (MAIC) study of efficacy of BAY 81-8973 with antihemophilic factor (recombinant) plasma/albumin-free method (rAHF-PFM) and turoctocog alfa for the...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:J Blood Med
Main Authors: Pocoski, Jennifer, Li, Nanxin, Ayyagari, Rajeev, Church, Nikki, Maas Enriquez, Monika, Xiang, Quer, Kelkar, Sneha, Du, Ella X, Wu, Eric Q, Xie, Jipan
Formato: Artigo
Idioma:Inglês
Publicado em: Dove Medical Press 2016
Assuntos:
Original Research
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4938137/
https://ncbi.nlm.nih.gov/pubmed/27445511
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/JBM.S104074
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados